Jiangzhong Pharmaceutical Co Ltd Financial Flexibility Index
Jiangzhong Pharmaceutical Co Ltd financial flexibility index. Jiangzhong Pharmaceutical Co Ltd (600750) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of CN¥74.16 Million (operating CF CN¥-2.91 Million minus capex CN¥77.07 Million) represents 0% of total liabilities (CN¥2.18 Billion). See 600750 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jiangzhong Pharmaceutical Co Ltd (1998–2025)
Financial flexibility index of Jiangzhong Pharmaceutical Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Jiangzhong Pharmaceutical Co Ltd across 28 annual periods. Check Jiangzhong Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Jiangzhong Pharmaceutical Co Ltd Financial Flexibility Index by Year (1998–2025)
Jiangzhong Pharmaceutical Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Jiangzhong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600750 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.57x | CN¥1.25 Billion | CN¥970.87 Million | CN¥2.18 Billion | ▲ +8.6% |
| 2024 | 0.53x | CN¥1.08 Billion | CN¥786.25 Million | CN¥2.04 Billion | ▼ -24.7% |
| 2023 | 0.70x | CN¥1.24 Billion | CN¥1.04 Billion | CN¥1.77 Billion | ▼ -9.2% |
| 2022 | 0.77x | CN¥1.37 Billion | CN¥1.02 Billion | CN¥1.77 Billion | ▼ -1.0% |
| 2021 | 0.78x | CN¥1.11 Billion | CN¥917.04 Million | CN¥1.42 Billion | ▼ -43.8% |
| 2020 | 1.39x | CN¥935.04 Million | CN¥752.50 Million | CN¥672.27 Million | ▲ +61.8% |
| 2019 | 0.86x | CN¥717.51 Million | CN¥641.18 Million | CN¥834.84 Million | ▼ -20.3% |
| 2018 | 1.08x | CN¥607.62 Million | CN¥486.25 Million | CN¥563.53 Million | ▲ +58.0% |
| 2017 | 0.68x | CN¥306.14 Million | CN¥124.93 Million | CN¥448.74 Million | ▼ -60.0% |
| 2016 | 1.71x | CN¥768.11 Million | CN¥698.05 Million | CN¥449.96 Million | ▼ -3.6% |
| 2015 | 1.77x | CN¥573.53 Million | CN¥510.78 Million | CN¥323.74 Million | ▲ +360.7% |
| 2014 | 0.38x | CN¥459.14 Million | CN¥356.80 Million | CN¥1.19 Billion | ▲ +87.2% |
| 2013 | 0.21x | CN¥176.51 Million | CN¥111.92 Million | CN¥859.15 Million | ▼ -46.4% |
| 2012 | 0.38x | CN¥450.80 Million | CN¥226.38 Million | CN¥1.18 Billion | ▼ -38.1% |
| 2011 | 0.62x | CN¥415.84 Million | CN¥168.30 Million | CN¥671.11 Million | ▲ +24.0% |
| 2010 | 0.50x | CN¥363.16 Million | CN¥222.29 Million | CN¥726.93 Million | ▼ -34.1% |
| 2009 | 0.76x | CN¥397.68 Million | CN¥378.32 Million | CN¥524.73 Million | ▲ +61.5% |
| 2008 | 0.47x | CN¥289.37 Million | CN¥268.87 Million | CN¥616.73 Million | ▲ +9.3% |
| 2007 | 0.43x | CN¥164.79 Million | CN¥153.63 Million | CN¥383.89 Million | ▲ +184.7% |
| 2006 | 0.15x | CN¥85.94 Million | CN¥55.24 Million | CN¥569.95 Million | ▼ -74.3% |
| 2005 | 0.59x | CN¥263.87 Million | CN¥198.45 Million | CN¥449.20 Million | ▲ +1.9% |
| 2004 | 0.58x | CN¥289.31 Million | CN¥26.28 Million | CN¥501.74 Million | ▼ -35.5% |
| 2003 | 0.89x | CN¥310.40 Million | CN¥78.98 Million | CN¥347.14 Million | ▼ -29.6% |
| 2002 | 1.27x | CN¥210.31 Million | CN¥94.90 Million | CN¥165.58 Million | ▲ +141.8% |
| 2001 | 0.53x | CN¥46.34 Million | CN¥41.28 Million | CN¥88.23 Million | ▼ -42.6% |
| 2000 | 0.92x | CN¥148.99 Million | CN¥121.77 Million | CN¥162.71 Million | ▲ +938.5% |
| 1999 | -0.11x | CN¥-17.63 Million | CN¥-21.89 Million | CN¥161.46 Million | ▼ -356.9% |
| 1998 | 0.04x | CN¥6.10 Million | CN¥-11.42 Million | CN¥143.42 Million | — |